Martin Reeves
AUTHOR

Martin Reeves

Business & Careers
Tap the gear icon above to manage new release emails.
Martin Reeves is a managing director and senior partner in BCG’s San Francisco office, and the Chairman of the BCG Henderson Institute (BHI), BCG’s vehicle for exploring ideas from beyond the world of business, which have implications for business strategy management. Martin’s latest book, The Imagination Machine (HBR Press, 2021 June) explores how to systematically harness imagination to generate new ideas and transform your business. He is editor of the “Inspiring the Next Game” book series, a set of perspectives on emerging themes in business published in partnership between De Gruyter and the BCG Henderson Institute: · Sustainable Business Model Innovation (2023) · The Rise of AI-Powered Companies (2022) · Business Ecosystems (2022) · New Leadership Imperatives (2022) · Dynamics Business Strategy (2021) · The Resilient Enterprise (2021) · Winning the ’20s (2021) · Mastering the Science of Organizational Change (2021) Martin is also the co-author of Your Strategy Needs a Strategy (HBR Press, 2015) and host of the Thinkers & Ideas podcast, where he interviews leading thinkers about influential ideas on business, technology, economics, and science. He is a regular contributor to Harvard Business Review, MIT Sloan Management Review, Fortune, and other management journals on business strategy and management. Martin holds a triple first-class MA in natural sciences from Cambridge University and an MBA from Cranfield School of Management. To learn more about Martin’s latest research visit The BCG Henderson Institute's website, subscribe to BHI’s newsletter or connect with him on social media.
Read more Read less

Best Sellers

Product List
  • The Imagination Machine cover art

    Regular price: ₹586.00 or 1 Credit

    Sale price: ₹586.00 or 1 Credit

    Free with 30-day trial
  • Your Strategy Needs a Strategy cover art

    Regular price: ₹586.00 or 1 Credit

    Sale price: ₹586.00 or 1 Credit

    Free with 30-day trial